image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.1
-0.901 %
$ 139 M
Market Cap
-3.14
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one OGI stock under the worst case scenario is HIDDEN Compared to the current market price of 1.1 USD, OrganiGram Holdings Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one OGI stock under the base case scenario is HIDDEN Compared to the current market price of 1.1 USD, OrganiGram Holdings Inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one OGI stock under the best case scenario is HIDDEN Compared to the current market price of 1.1 USD, OrganiGram Holdings Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart OGI

image
$1.8$1.8$1.7$1.7$1.6$1.6$1.5$1.5$1.4$1.4$1.3$1.3$1.2$1.2$1.1$1.1$1.0$1.0$0.9$0.9$0.8$0.815 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
160 M REVENUE
7.13%
-35.7 M OPERATING INCOME
26.89%
-45.4 M NET INCOME
80.20%
3.87 M OPERATING CASH FLOW
110.82%
-38.8 M INVESTING CASH FLOW
-849.53%
108 M FINANCING CASH FLOW
14391.38%
42.7 M REVENUE
-4.40%
-11.3 M OPERATING INCOME
-3994.70%
-23 M NET INCOME
-322.55%
-4.18 M OPERATING CASH FLOW
-47.00%
-61.6 M INVESTING CASH FLOW
-174.61%
-202 K FINANCING CASH FLOW
-0.49%
Balance Sheet OrganiGram Holdings Inc.
image
Current Assets 262 M
Cash & Short-Term Investments 108 M
Receivables 37.2 M
Other Current Assets 118 M
Non-Current Assets 146 M
Long-Term Investments 40.7 M
PP&E 96.2 M
Other Non-Current Assets 8.68 M
26.37 %9.11 %28.81 %9.99 %23.59 %Total Assets$407.9m
Current Liabilities 53.3 M
Accounts Payable 47.1 M
Short-Term Debt 1.09 M
Other Current Liabilities 5.14 M
Non-Current Liabilities 48.5 M
Long-Term Debt 3.37 M
Other Non-Current Liabilities 45.2 M
46.23 %5.04 %3.31 %44.35 %Total Liabilities$101.9m
EFFICIENCY
Earnings Waterfall OrganiGram Holdings Inc.
image
Revenue 160 M
Cost Of Revenue 112 M
Gross Profit 47.5 M
Operating Expenses 83.2 M
Operating Income -35.7 M
Other Expenses 9.77 M
Net Income -45.4 M
200m200m150m150m100m100m50m50m00(50m)(50m)160m(112m)48m(83m)(36m)(10m)(45m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
29.73% GROSS MARGIN
29.73%
-22.32% OPERATING MARGIN
-22.32%
-28.43% NET MARGIN
-28.43%
-14.85% ROE
-14.85%
-11.14% ROA
-11.14%
-8.86% ROIC
-8.86%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis OrganiGram Holdings Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)(160m)(160m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -45.4 M
Depreciation & Amortization 12.1 M
Capital Expenditures -5.34 M
Stock-Based Compensation 7.18 M
Change in Working Capital 15 M
Others 42.1 M
Free Cash Flow -1.47 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets OrganiGram Holdings Inc.
image
OGI has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership OrganiGram Holdings Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC b. businesswire.com - 1 week ago
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick (“ONB”) as part of the 2025 New Brunswick Export Awards, ONB's flagship annual event recognizing the successes and innovative approaches of New Brunswick's many exporting companies. This honour recognizes Organigram's significant growth in internationa. businesswire.com - 2 weeks ago
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi. businesswire.com - 2 weeks ago
Organigram Global's Products Recognized at the CNB Awards TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that three of its consumer brands — SHRED, Edison, and Trailblazer — earned honours at the recent CNB Leadership Conference and the Cannabis NB Cup. Inspired by the legacy events that have shaped cannabis culture over the years, the Cannabis NB Cup celebrates the best in grow — with winners chosen by those who matter mos. businesswire.com - 3 weeks ago
Organigram Global Shares Recording of its OG Investor Session TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. “This session was a way for Organigram to engage directly with investors and industry stak. businesswire.com - 4 weeks ago
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada's economy through homegrown industries, including the legal cannabis sector. The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 20251, arrives at a pivotal moment for Canada's economic and political futu. businesswire.com - 1 month ago
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key ind. businesswire.com - 1 month ago
Organigram Enters U.S. Through Acquisition of Collective Project Beverages TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited (“CPL”) for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and Septembe. businesswire.com - 1 month ago
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. (“Organigram Global”), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the number one position in market share in Canada1 and established a growing international footprint, Orga. businesswire.com - 1 month ago
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc. TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the. businesswire.com - 1 month ago
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T. businesswire.com - 2 months ago
Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales. seekingalpha.com - 2 months ago
8. Profile Summary

OrganiGram Holdings Inc. OGI

image
COUNTRY CA
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 139 M
Dividend Yield 0.00%
Description Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Contact 35 English Drive, Moncton, NB, E1E 3X3 https://www.organigram.ca
IPO Date May 21, 2019
Employees 1093
Officers Mr. Timothy Emberg Chief Commercial Officer Mr. Paolo De Luca C.A., C.F.A Chief Strategy Officer Max Schwartz Director of Investor Relations Mr. Gregory Engel Special Advisor Mr. Greg Guyatt C.A., CPA Chief Financial Officer Ms. Helen Martin Chief Legal Officer & Corporate Secretary Mr. Geoffrey John Riggs Chief Information Officer Ms. Nathalie Batten Kubrick Executive Vice President of Operations Ms. Katrina May McFadden Chief People Officer Ms. Beena G. Goldenberg Chief Executive Officer & Director